INmune Bio, Inc.
INMBDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
2dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
INMB Earnings Report
FQ end 2026-06 | Call: 2026-08-06 15:00:00
How INMB's past catalysts played out
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in INmune Bio, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in INmune Bio, Inc.'s (INMB) pipeline across Phase 2. Its lead program is INKmune (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is INmune Bio, Inc.'s next FDA catalyst?→
INmune Bio, Inc.'s (INMB) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track INMB biotech catalysts?→
Add INMB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow INmune Bio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.